BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim MW, Niidome T, Lee R. Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer. Mar Drugs 2019;17:E581. [PMID: 31614820 DOI: 10.3390/md17100581] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Saeed AFUH, Su J, Ouyang S. Marine-derived drugs: Recent advances in cancer therapy and immune signaling. Biomed Pharmacother 2021;134:111091. [PMID: 33341044 DOI: 10.1016/j.biopha.2020.111091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
2 Lutz H, Hu S, Dinh P, Cheng K. Cells and cell derivatives as drug carriers for targeted delivery. Medicine in Drug Discovery 2019;3:100014. [DOI: 10.1016/j.medidd.2020.100014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 4.7] [Reference Citation Analysis]
3 Ryu JH, Yoon HY, Sun IC, Kwon IC, Kim K. Tumor-Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity. Adv Mater 2020;32:e2002197. [PMID: 33051905 DOI: 10.1002/adma.202002197] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
4 Le-deygen IM, Skuredina AA, Kudryashova EV. Experimental Methods to Study the Mechanisms of Interaction of Lipid Membranes with Low-Molecular-Weight Drugs. Russ J Bioorg Chem 2020;46:480-97. [DOI: 10.1134/s1068162020040123] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dos Santos KC, Dos Reis LR, Rodero CF, Sábio RM, Junior AGT, Gremião MPD, Chorilli M. Bioproperties, Nanostructured System and Analytical and Bioanalytical Methods for Determination of Rapamycin: A Review. Crit Rev Anal Chem 2020;:1-9. [PMID: 33138632 DOI: 10.1080/10408347.2020.1839737] [Reference Citation Analysis]
6 Madamsetty VS, Tavakol S, Moghassemi S, Dadashzadeh A, Schneible JD, Fatemi I, Shirvani A, Zarrabi A, Azedi F, Dehshahri A, Aghaei Afshar A, Aghaabbasi K, Pardakhty A, Mohammadinejad R, Kesharwani P. Chitosan: A versatile bio-platform for breast cancer theranostics. J Control Release 2021;341:733-52. [PMID: 34906606 DOI: 10.1016/j.jconrel.2021.12.012] [Reference Citation Analysis]
7 De Leo V, Milano F, Agostiano A, Catucci L. Recent Advancements in Polymer/Liposome Assembly for Drug Delivery: From Surface Modifications to Hybrid Vesicles. Polymers (Basel) 2021;13:1027. [PMID: 33810273 DOI: 10.3390/polym13071027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Nwabuife JC, Pant AM, Govender T. Liposomal delivery systems and their applications against Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus. Adv Drug Deliv Rev 2021;:113861. [PMID: 34242712 DOI: 10.1016/j.addr.2021.113861] [Reference Citation Analysis]
9 Wang G, Li R, Parseh B, Du G. Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review. Carbohydr Polym 2021;268:118192. [PMID: 34127212 DOI: 10.1016/j.carbpol.2021.118192] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sato W, Zajkowski T, Moser F, Adamala KP. Synthetic cells in biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1761. [PMID: 34725945 DOI: 10.1002/wnan.1761] [Reference Citation Analysis]